- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
Feb 23, 2013
From
MARKETS
Feb 23, 2013
Phytopharm falls after drug test failure
Trial for Parkinson’s treatment shows drug has no effects
©Reuters
Feb 22, 2013
Vasella admits mistakes over $78m payout
Shareholders not appeased by Novartis chairman’s concession
From
WORLD
Feb 20, 2013
Pryce faces retrial after jury discharged
Circumstances of case raise questions about jury system
From
TECHNOLOGY
Feb 20, 2013
Winners of life science prize revealed
Silicon Valley billionaires pledge $50m
- Gillian Tett More US lawyers move into the boardroom
- Roger Altman Deal to avoid US fiscal crunch
©AFP/Getty Images
Feb 19, 2013
Novartis scraps chairman’s $78m payout
Shareholder anger forces U-turn on Vasella
- Analysis Novartis pay criticism unlikely to abate
- John Gapper The flaw in paying for executive loyalty
©Reuters
Feb 18, 2013
Novartis chairman’s pay-off sparks anger
Vasella to be given SFr72m ‘golden goodbye’ for confidentiality
From
WORLD
Feb 18, 2013
Suffering side-effects of health reform
Critics see threat to Obamacare goals
From
LEX
Feb 18, 2013
Novartis: Vasella-tions
Swiss drugs group’s chairman should not have accepted $78m payment
Feb 15, 2013
Icahn steps up Herbalife fight with Ackman
Activist investor lifts pressure by building a 13% stake
From
HEALTH CARE
Feb 14, 2013
Cardinal in $2bn AssuraMed home care deal
Remote care increasingly important due to Obama incentives
From
TECHNOLOGY
Feb 14, 2013
Fish threatened by exposure to tranquilliser
Swedish study raises alarm over ecological effects of medicines
Feb 12, 2013
FDA rejects Novo Nordisk insulin remedy
Shares in Danish drugmaker fall 13% after setback
From
LEX
Feb 11, 2013
Novo Nordisk: reality check
The specialist in diabetic treatments gets hit by an FDA ruling
Multimedia
Novartis did right by scrapping its $78m loyalty payment to outgoing chief Daniel Vasella
business blog
Novartis did right by scrapping its $78m loyalty payment to outgoing chief Daniel Vasella
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
-
Chief Executive, Shareholder Executive
BIS
-
VP EUROPEAN SALES
Manufacturing
-
Senior Analyst, NA Gas Infrastructure Pipeline
Wood Mackenzie
-
Chief Financial Officer
Marine Transportation Industry
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Novartis pay criticism unlikely to abate
The group is still likely to face an uncomfortable grilling, write James Shotter and Andrew Jack